These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 16844690
21. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D, Fukuda A, Imai M, Okada H. J Physiol; 2002 Mar 01; 539(Pt 2):537-45. PubMed ID: 11882685 [Abstract] [Full Text] [Related]
22. Mapping the active site of CD59. Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S. J Exp Med; 1997 Feb 17; 185(4):745-53. PubMed ID: 9034152 [Abstract] [Full Text] [Related]
23. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8. Lehto T, Meri S. J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959 [Abstract] [Full Text] [Related]
26. Insights into the human CD59 complement binding interface toward engineering new therapeutics. Huang Y, Smith CA, Song H, Morgan BP, Abagyan R, Tomlinson S. J Biol Chem; 2005 Oct 07; 280(40):34073-9. PubMed ID: 16079145 [Abstract] [Full Text] [Related]
27. Structural basis for membrane attack complex inhibition by CD59. Couves EC, Gardner S, Voisin TB, Bickel JK, Stansfeld PJ, Tate EW, Bubeck D. Nat Commun; 2023 Feb 16; 14(1):890. PubMed ID: 36797260 [Abstract] [Full Text] [Related]
28. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Pausa M, Pellis V, Cinco M, Giulianini PG, Presani G, Perticarari S, Murgia R, Tedesco F. J Immunol; 2003 Mar 15; 170(6):3214-22. PubMed ID: 12626580 [Abstract] [Full Text] [Related]
29. Crystal structure of complement protein C8gamma in complex with a peptide containing the C8gamma binding site on C8alpha: implications for C8gamma ligand binding. Lovelace LL, Chiswell B, Slade DJ, Sodetz JM, Lebioda L. Mol Immunol; 2008 Feb 15; 45(3):750-6. PubMed ID: 17692377 [Abstract] [Full Text] [Related]
30. Identification of mutations in rat CD59 that increase the complement regulatory activity. Hinchliffe SJ, Morgan BP. Biochemistry; 2000 May 16; 39(19):5831-7. PubMed ID: 10801333 [Abstract] [Full Text] [Related]
31. Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis. Tomlinson S, Wang Y, Ueda E, Esser AF. J Immunol; 1995 Jul 01; 155(1):436-44. PubMed ID: 7541424 [Abstract] [Full Text] [Related]
34. Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis. Zhu X, Gao M, Ren S, Wang Q, Lin C. Cell Mol Immunol; 2008 Apr 01; 5(2):141-6. PubMed ID: 18445344 [Abstract] [Full Text] [Related]
36. An indel within the C8 alpha subunit of human complement C8 mediates intracellular binding of C8 gamma and formation of C8 alpha-gamma. Plumb ME, Sodetz JM. Biochemistry; 2000 Oct 24; 39(42):13078-83. PubMed ID: 11041874 [Abstract] [Full Text] [Related]
37. Immunohistochemical localization of C9 neoantigen and the terminal complement inhibitory protein CD59 in human endometrium. Ratnoff WD, Brockman WW, Hasty LA. Am J Reprod Immunol; 1995 Aug 24; 34(2):72-9. PubMed ID: 8526992 [Abstract] [Full Text] [Related]
38. Topology of the membrane-bound form of complement protein C9 probed by glycosylation mapping, anti-peptide antibody binding, and disulfide modification. Rossi V, Wang Y, Esser AF. Mol Immunol; 2010 Apr 24; 47(7-8):1553-60. PubMed ID: 20153530 [Abstract] [Full Text] [Related]
39. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins. Koski CL, Estep AE, Sawant-Mane S, Shin ML, Highbarger L, Hansch GM. J Neurochem; 1996 Jan 24; 66(1):303-12. PubMed ID: 8522968 [Abstract] [Full Text] [Related]